Worldwide Clinical Trials

San Antonio, Texas 78217

1 studies enrolling now · 60 studies all time

What they study most

Acute Gout Flare, Alzheimer Disease, Alzheimer Disease, Early Onset, Amyotrophic Lateral Sclerosis (ALS), Becker Muscular Dystrophy, Body Weight, Cerebral Palsy, Diabetes Complications, Diabetes Mellitus, Diabetes Mellitus, Type 1, Diabetic Nephropathies, Drug Sensitive Tuberculosis

Studies at this site

• A Study of PF-08653945 and PF-08653944 in Adults With Overweight or Obesity (SOLIS-1) — Recruiting now
• Single-dose Pharmacokinetics of Pociredir in Participants With Sickle Cell Disease — Stopped early
• Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals — Completed
• A Clinical Trial to Study Single- and Multiple- Doses of GSM-779690T in Healthy Participants — Withdrawn before enrolling
• A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Oral ABP-745 Administration in Healthy Volunteers — Completed
• Extension Study of ABP-671 in Participants With Gout — Stopped early
• Evaluate Safety, Tolerability, PK of TBAJ-876 in Healthy Adults — Completed
• A First in Human Study of ORT247 in Healthy Volunteers — Completed
• A Study Comparing the Safety, Tolerability, and Pharmacokinetics of Sabirnetug IV and Sabirnetug + rHuPH20 SC in Healthy Participants — Completed
• A Study To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2086 in Healthy Adult and Elderly Participants — Completed
• Pharmacokinetic Study of 5 and 10 mg Corplex™ Donepezil TDS Compared to 10 mg Aricept® in Healthy Volunteers — Completed
• A Randomized, Open-label, Three-way Crossover Study to Evaluate the Relative Bioavailability of 200 Mg Cenobamate Administered Orally — Completed
• Study to Assess Repeated Doses of INDV-2000 in Healthy Volunteers and in Treatment Seeking Individuals With Opioid Use Disorder — Completed
• Pharmacokinetic Evaluation of Intranasal Nalmefene — Completed
• Pharmacokinetic Evaluation of Intranasal Nalmefene Using Three Dosing Regimens — Completed
• Effect of Food on the Pharmacokinetics of ASTX660 in Healthy Volunteers — Completed
• Phase 2, Randomized, Open-Label, Crossover, PD/PK Study of a Novel Pram-Insulin Co-Formulation in Adults With T1D — Completed
• A Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of E2025 in Healthy Participants — Completed
• Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of PIPE-791 and Food Effect in Healthy Volunteers — Completed
• A Study to Assess the Effect of Cefiderocol on the Pharmacokinetics (PK) of Midazolam in Healthy Participants — Completed
• Study to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy Subjects — Completed
• A Study of a Single Ascending Dose Study of DS-7011a in Healthy Subjects — Completed
• A Study to Assess Safety, Tolerability, Pharmacokinetics (PK), Immunogenicity, and Pharmacodynamics (PD) of Intravenous Infusions of E2814 in Healthy Participants — Completed
• A Study to Assess the Safety and Pharmacokinetics of Single Ascending Subcutaneous and Intravenous Doses of DS-2325a in Healthy Subjects — Completed
• OTO-313 in Subjects With Subjective Tinnitus — Completed
• FX-322 in Sensorineural Hearing Loss — Completed
• Study to Evaluate the Safety, Tolerability, PK and PD of DISC-0974 in Healthy Subjects — Completed
• A Study to Assess Safety, Tolerability, and PK of EDG-5506 in Healthy Volunteers and Becker Muscular Dystrophy Adults — Completed
• A Study of the Effect of a Moderate CYP3A Inducer Efavirenz on Quizartinib Pharmacokinetics in Healthy Participants — Completed
• First-In-Human Study of GFB-024 in Healthy Overweight and Obese Participants, and Participants With Type 2 Diabetes — Completed
• Study of PK, Safety, and Tolerability of 2 Lots of M207 & Intranasal Zolmitriptan in Healthy Volunteers — Completed
• A Study to Assess the Safety and Tolerability of E2511 in Healthy Participants — Completed
• A Study of the Effect of Quizartinib on the Pharmacokinetics of the P-gp Substrate Dabigatran Etexilate in Healthy Participants — Completed
• Study to Evaluate the Safety, Tolerability, and PK of Fulvestrant After IM Administration — Completed
• A Safety Study of PTI-125 in Healthy Volunteers — Completed
• Study of Single-dose DS-3201b in Participants With Hepatic Impairment — Completed
• Relative Bioavailability Study of MELT-100, IV Midazolam, and IV Ketamine — Completed
• Safety and Tolerability of PNT001 in Healthy Adults — Completed
• Effect of Low-Fat Food on Pexidartinib Pharmacokinetics in Healthy Volunteers — Completed
• Safety and Pharmacokinetics of Sustained-release Depot Tacrolimus: A First-in-human Study — Completed
• The Effect of CS-3150 Exposure on Corrected QT (QTc) Interval Duration in Healthy Volunteers — Completed
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Norketotifen in Healthy Subjects — Completed
• A Study Assessing the Mass Balance of a Single Oral Dose of [14C] DS-8500a in Healthy Subjects — Completed
• A Study to Determine the Effects of Itraconazole on the Pharmacokinetics (PK) of DS-8500 in Healthy Subjects — Completed
• A Study to Compare Bioavailability of Naloxone Nasal Spray and Naloxone Hydrochloride (HCl) Intramuscular Injection (IM) in Healthy Volunteers — Completed
• A Study to Compare Bioavailability of Naloxone Nasal Spray, Naloxone Hydrochloride (HCl) Intravenous (IV) and Intramuscular Injection (IM) in Healthy Volunteers — Completed
• A Study to Demonstrate Bioequivalence Between Lorcaserin Extended Release (XR) Tablets Manufactured in Kawashima and Lorcaserin XR Tablets Manufactured in Zofingen in Healthy Participants — Completed
• A Phase 1 Study to Evaluate Safety, Tolerability, PK, and PK Interactions of TBA-7371 — Completed
• Study to Assess the Pharmacokinetic Drug-Drug Interactions of Lemborexant When Coadministered With an Oral Contraceptive, Famotidine, or Fluconazole in Healthy Subjects — Completed
• Evaluation of the Accuracy of an Implanted Glucose Sensor — Completed